- Home
- EMBC
EMBC
Embecta Corp.
as of 03-04-2026 3:41pm EST
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
| Founded: | 1924 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 602.3M | IPO Year: | 2021 |
| Target Price: | $18.50 | AVG Volume (30 days): | 905.0K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | semi-annual | |
| EPS: | 0.74 | EPS Growth: | 20.90 |
| 52 Week Low/High: | $9.20 - $15.55 | Next Earning Date: | 05-11-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 1.17% | Revenue Growth (next year): | -0.09% |
| P/E Ratio: | 13.01 | Index: | N/A |
| Free Cash Flow: | 182.4M | FCF Growth: | +612.11% |
AI-Powered EMBC Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 5, 2026 · 100% conf.
Q4 2025 Earnings
8-K SELLFeb 5, 2026 · 100% conf.
1D
-2.63%
$10.19
5D
-7.11%
$9.73
20D
-12.11%
$9.20
embc-202602050001872789FALSE00018727892026-02-052026-02-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026
EMBECTA CORP.
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On February 5, 2026, Embecta Corp. issued a press release (the “Press Release”) regarding its results for the quarter ended December 31, 2025. The Press Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated February 5, 2026.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EMBECTA CORP.
Dated: February 5, 2026 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 25, 2025
Q3 2025 Earnings
8-KNov 25, 2025
embc-202511250001872789FALSE00018727892025-11-252025-11-25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2025
EMBECTA CORP.
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On November 25, 2025, Embecta Corp. (the “Company”) issued a press release (the “Earnings Release”) regarding its results for the quarter and fiscal year ended September 30, 2025. The Earnings Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated November 25, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EMBECTA CORP.
Dated: November 25, 2025 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Aug 8, 2025
Q2 2025 Earnings
8-KAug 8, 2025
embc-202508080001872789FALSE00018727892025-08-082025-08-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2025
EMBECTA CORP.
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On August 8, 2025, Embecta Corp. issued a press release (the “Press Release”) regarding its results for the quarter ended June 30, 2025. The Press Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated August 8, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EMBECTA CORP.
Dated: August 8, 2025 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Compare EMBC vs Leading Stocks
See how EMBC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "EMBC Embecta Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.